Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TLV/BLRX stock hub

TLV/BLRX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TLV/BLRXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
41.8M
Tel Aviv Stock Exchange
Market data

Price

Recent price action with selectable time range.

TLV/BLRXTLV/BLRX
—
Loading chart…
In the news

Latest news · TLV/BLRX

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-11
P25 n/aP50 n/aP75 n/a
ROIC-20.7
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TLV/BLRX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
180
Groups with data
11
Currency
USD
Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Israel
Country code
IL
Employees
24
Employees Change
-4%
Employees Change Percent
-14.29
Enterprise value
ILA 24M
Exchange
Tel Aviv Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biotechnology
Isin
IL0011015182
Last refreshed
2026-05-10
Market cap
ILA 41.8M
Price
ILA 1.6
Price currency
ILA
Rev Per Employee
170,992.73x
Sector
Healthcare
Sic
2836
Symbol
tlv/BLRX
Website
https://www.biolinerx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-8.97%
EV Earnings
-6.41x
EV/FCF
-0.93x
EV/Sales
6.38x
FCF yield
-61.81%
P/B ratio
0.56x
P/S ratio
11.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

16
MetricValue
Gross margin
80.51%
Gross Profit
ILA 3M
Gross Profit Growth
-95.17%
Gross Profit Growth Q
-97.28%
Net Income
ILA -3.7M
Net Income Growth Quarters
2%
Net Income Growth Years
2%
Pretax Margin
-171.69%
Profit Margin
-99.58%
Profit Per Employee
ILA -170,268
ROA
-16.11
Roa5y
-24.97
ROCE
-35.74
ROE
-11.01
Roe5y
-74.27
ROIC
-20.74

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

10
MetricValue
Cagr10y
-41.88%
Cagr15y
-38.24%
Cagr1y
-20.01%
Cagr3y
-61.47%
Cagr5y
-54.34%
EPS Growth Quarters
2
EPS Growth Years
2
Revenue Growth
-95.92x
Revenue Growth Q
-98.35x
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
ILA 0.03
Assets
ILA 130.4M
Cash
ILA 66.6M
Current Assets
ILA 68.7M
Current Liabilities
ILA 35.2M
Debt
ILA 32.4M
Debt Equity
ILA 0.43
Debt FCF
ILA -1.25
Equity
ILA 74.4M
Interest Coverage
-8.22
Liabilities
ILA 56M
Long Term Assets
ILA 61.7M
Long Term Liabilities
ILA 20.8M
Net Cash
ILA 34.2M
Net Cash By Market Cap
ILA 81.86
Net Cash Growth
137.2%
Net Debt Equity
ILA -0.46
Tangible Book Value
ILA 5.8M
Tangible Book Value Per Share
ILA 0
WACC
8.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.95
Inventory Turnover
0.09
Net Working Capital
ILA -14.7M
Quick ratio
1.76
Working Capital
ILA 36.8M
Working Capital Turnover
ILA 0.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-105.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
10Y total return
-99.56%
1Y total return
-20%
200-day SMA
1.8
3Y total return
-94.29%
50-day SMA
1.39
50-day SMA vs 200-day SMA
50under200
5Y total return
-98.01%
All Time High
6,666
All Time High Change
-99.98%
All Time High Date
2007-02-14
All Time Low
1.1
All Time Low Change
45.45%
All Time Low Date
2026-04-28
ATR
0.13
Beta
0.59
Beta1y
0.75
Beta2y
0.83
High
1.7
High52
3.9
High52 Date
2025-06-09
High52ch
-58.97%
Low
1.5
Low52
1.1
Low52 Date
2026-04-28
Low52ch
45.46%
Ma50ch
14.78%
Price vs 200-day SMA
-10.96%
RSI
60.23
RSI Monthly
29.59
RSI Weekly
55.25
Sharpe ratio
0.22x
Sortino ratio
0.43
Total Return
-105.76%
Tr15y
-99.93%
Tr1m
23.08%
Tr1w
14.29%
Tr3m
6.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
ILA -32.8M
Operating margin
-871.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
2,498,163,190%
Net Borrowing
-14,534,010
Shares Insiders
0.39%
Shares Institutions
3.97%
Shares Out
2,610,814,390
Shares Qo Q
2.12%
Shares Yo Y
105.76%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

54
MetricValue
Adjusted FCF
ILA -27.1M
Average Volume
7,345,160x
Bv Per Share
0.02
CAPEX
ILA -79,700
Ch10y
-99.56
Ch15y
-99.93
Ch1m
23.08
Ch1w
14.29
Ch1y
-20
Ch3m
6.67
Ch3y
-94.29
Ch5y
-98.01
Ch6m
-11.11
Change
-5.88%
Change From Open
0
Close
1.7
Days Gap
-5.88
Depreciation Amortization
658,527
Dollar Volume
6,785,411.2
Earnings Date
2026-05-26
EBIT
ILA -32.8M
EBITDA
ILA -32.1M
EPS
ILA -0
F Score
3
FCF
ILA -25.8M
FCF EV Yield
-107.61x
FCF Per Share
ILA -0.01
Financing CF
28,322,192
Fiscal Year End
December
Founded
2,003
Investing CF
-27,241,460
Is Primary Listing
1
Last Earnings Date
2026-03-23
Last Report Date
2025-12-31
Last Split Date
2015-06-07
Last Split Type
Reverse
Ma150
1.65
Ma150ch
-2.74%
Ma20
1.37
Ma20ch
16.79%
Net CF
-22,908,968
Next Earnings Date
2026-05-26
Open
1.6
Position In Range
50
Ppne
2,483,256
Price Date
2026-05-08
Ptbv Ratio
7.17
Relative Volume
0.58x
Revenue
3,761,840x
SBC By Revenue
33.56x
Share Based Comp
1,262,448
Tr6m
-11.11%
Volume
4,240,882
Z Score
-13.64
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TLV/BLRX pay a dividend?

Capital-return profile for this ticker.

Performance

TLV/BLRX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-20.0%
S&P 500 1Y: n/a
3Y total return
-94.3%
S&P 500 3Y: n/a
5Y total return
-98.0%
S&P 500 5Y: n/a
10Y total return
-99.6%
S&P 500 10Y: n/a
Ownership

Who owns TLV/BLRX?

Insider, institutional, and short-interest positioning.

Institutional ownership
+4.0%
Share of float held by funds and institutions
Insider ownership
+0.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+105.8%
Negative means the company is buying back shares.
Technical

TLV/BLRX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
60.2
Neutral momentum band
Price vs 200-day MA
-11.0%
50/200-day relationship not available
Beta (5Y)
0.59
Less volatile than the market
Sharpe ratio
0.22
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TLV/BLRX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/BLRX stock rating?

tlv/BLRX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/BLRX analysis?

The full report lives at /stocks/tlv/BLRX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/BLRX?

The latest report frames tlv/BLRX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/BLRX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.